Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Cancer. 2020 Dec 22;127(9):1417–1424. doi: 10.1002/cncr.33379

Table 2.

Frequency of Treatment Related Adverse Events and Laboratory Abnormalities.

Event Any Grade Grade ≥ 3
Any event – no. (%) 41 (100) 14 (34)
Any serious event – no. (%) 1 (2) 1 (2)
Most common events – no. (%)
 Fatigue 24 (59) 1 (2)
 Nausea 21 (51) 0
 Anorexia 10 (24) 0
 Diarrhea 9 (22) 1 (2)
 Vomiting 9 (22) 0
 Peripheral sensory neuropathy 6 (15) 1 (2)
Laboratory Abnormalities – no. (%)
 Anemia 19 (46) 2 (5)
 Neutrophil count decrease 16 (39) 8 (20)
 Lymphocyte count decrease 12 (29) 4 (10)
 Platelet count decreased 13 (32) 2 (5)
 White blood cell count decreased 10 (24) 3 (7)
 Alkaline phosphatase increased 6 (15) 0

AE with > 10% incidence